Cipla | LinkedIn

Cipla is top GAINER on Nifty today, expert says BUY this share with price target of Rs 978

Cipla pacifies chemists' lobby, says ‘no plans’ to partner Medlife

Cipla Q2 earnings preview: Margins under pressure as US, domestic sales outlook remains modest

Cipla shares top Nifty 50 losers after biggest fall in nine months; CNBC-TV18 accesses Pithampur warning letter - CNBC TV18

Cipla Vs Sun Pharma - Is Pharma Ready For A Turnaround? | Nithya Balasubramanian, Sanford Bernstein

Cipla shares trade within inches of record high; check out latest triggers for drug maker

India's Cipla: 'Huge wave' of pandemic-driven interest in health and wellness

India's Cipla beats estimates with 11% rise in quarterly profit